Previous 10 | Next 10 |
Gainers: Dova Pharmaceuticals (NASDAQ: DOVA ) +38% . USA Technologies ( OTC:USAT ) +28% . Farmmi (NASDAQ: FAMI ) +24% . Thor Industries (NYSE: THO ) +21% . GTT Communications (NYSE: GTT ) +15% . Patrick Industries (NASDAQ: PATK ) +12% . Seattle Genetics (NASDAQ: SGEN ) +10% . ...
Lexicon Pharmaceuticals (NASDAQ: LXRX ) is now off 13.8% today on heavy volume following a very bearish take from Seeking Alpha contributor Mako Research. More news on: Lexicon Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
The Sanofi termination is a disaster for LXRX shareholders and the cash burn will increase dramatically On July 25 th , Lexicon Pharmaceuticals ( LXRX ) received notice from Sanofi ( SNY ) ‘purporting’ to terminate their key alliance around the SGLT2 inhibitor sotagliflozin...
"Men in rage strike those that wish them best. ”― William Shakespeare, Othello The market broke its three-week winning streak last week. The Dow was off approximately one percent while the Russell 2000 declined just slightly more on a percentage basis. Both the S&P 500 a...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
Lexicon Pharmaceuticals (NASDAQ: LXRX ) is up 1.5% postmarket after an insider purchase from its CEO. More news on: Lexicon Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
Gainers: SPI Energy Co. (NASDAQ: SPI ) +42% . Lexicon Pharmaceuticals (NASDAQ: LXRX ) +22% . DAVIDsTEA (NASDAQ: DTEA ) +17% . Dynagas LNG Partners LP (NYSE: DLNG ) +12% . Edesa Biotech (NASDAQ: EDSA ) +12% . SCYNEXIS (NASDAQ: SCYX ) +11% . Eyenovia (NASDAQ: EYEN ) +10% . elect...
Gainers: Aclaris Therapeutics (NASDAQ: ACRS ) +68% . Avadel Pharmaceuticals plc (NASDAQ: AVDL ) +20% . BioCardia ( OTCQB:BCDA ) +15% . Lexicon Pharmaceuticals (NASDAQ: LXRX ) +14% . Earthstone Energy (NYSE: ESTE ) +14% . Pier 1 Imports (NYSE: PIR ) +15% . SunPower Corporation (...
News, Short Squeeze, Breakout and More Instantly...
Lexicon Pharmaceuticals Inc. Company Name:
LXRX Stock Symbol:
NASDAQ Market:
Lexicon Pharmaceuticals Inc. Website:
INPEFA ® (sotagliflozin) Net Sales of $1.6 Million in Q2 2024 Resubmitted NDA for ZYNQUISTA ™ (sotagliflozin) in Type 1 Diabetes, Launch Preparations Underway with PDUFA Goal Date of December 20, 2024 Commenced SONATA Phase 3 Study...
THE WOODLANDS, Texas, July 25, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its second quarter 2024 financial results on Thursday, August 1, 2024 after the markets close. Management will conduct a conference call and live webcast at 5:00 p.m. ET (4:00...
Launch Preparations Actively Underway; Launch Planned for Early 2025 Lexicon Seeks Approval for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease THE WOODLANDS, Texas, July 16, 20...